Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers

mBio

Volumn 10, Issue 1, 2019, Pages

  Baxter, Nielson T ^a,c   Schmidt, Alexander W ^a   Venkataraman, Arvind ^a,d   Kim, Kwi S ^a   Waldron, Clive ^a   Schmidt, Thomas M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ELANCO ANIMAL HEALTH   (United States)

^d PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Bifidobacteria; Butyrate; Microbiome; Prebiotic; Ruminococcus; SCFA

Indexed keywords

ACETIC ACID; BUTYRIC ACID; INULIN; PROPIONIC ACID; SHORT CHAIN FATTY ACID; STARCH; VOLATILE FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CHICORY; CLOSTRIDIUM; CLOSTRIDIUM CHARTATABIDUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; EUBACTERIUM RECTALE; FATTY ACID SYNTHESIS; FECES LEVEL; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; MAIZE; NONHUMAN; NORMAL HUMAN; PLANT ROOT; POPULATION ABUNDANCE; POTATO; PRIORITY JOURNAL; RUMINOCOCCUS; RUMINOCOCCUS BROMII; ADMINISTRATION AND DOSAGE; BIOSTATISTICS; CHEMICAL ANALYSIS; CHEMISTRY; DIETARY FIBER; DRUG EFFECT; FECES; METABOLISM; METAGENOMICS; MICROBIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOSTATISTICS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHICORY; DIETARY FIBER; FATTY ACIDS, VOLATILE; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; INULIN; METAGENOMICS; SOLANUM TUBEROSUM; STARCH; YOUNG ADULT; ZEA MAYS;

EID: 85060794638     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02566-18     Document Type: Article

References (45)

1. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Mu-rakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446–450. https://doi.org/10.1038/nature12721.
2. Peng L, Li ZR, Green RS, Holzman IR, Lin J. 2009. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139: 1619–1625. https://doi.org/10.3945/jn.109.104638.
3. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mito-chondrial pathway. Gut 52:94–100. https://doi.org/10.1136/gut.52.1.94.
4. Mikkelsen KH, Frost M, Bahl MI, Licht TR, Jensen US, Rosenberg J, Pedersen O, Hansen T, Rehfeld JF, Holst JJ, Vilsboll T, Knop FK. 2015. Effect of antibiotics on gut microbiota, gut hormones and glucose metabolism. PLoS One 10:e0142352. https://doi.org/10.1371/journal.pone.0142352.
5. Wang L, Luo HS, Xia H. 2009. Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway. J Int Med Res 37:803–811. https://doi.org/10.1177/147323000903700323.
6. Segain JP, de la Bietere DR, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP. 2000. Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn’s disease. Gut 47:397–403. https://doi.org/10.1136/gut.47.3.397.
7. Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, Schmidt TC, Honda K, Young VB, Pennathur S, van den Brink M, Reddy P. 2016. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 17:505–513. https://doi.org/10.1038/ni.3400.
8. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. 2009. Butyrate improves insulin sensitivity and increases energy expen-diture in mice. Diabetes 58:1509–1517. https://doi.org/10.2337/db08-1637.
9. Lin HV, Frassetto A, Kowalik EJ, Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ. 2012. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7:e35240. https://doi.org/10.1371/journal.pone.0035240.
10. Venkataraman A, Sieber JR, Schmidt AW, Waldron C, Theis KR, Schmidt TM. 2016. Variable responses of human microbiomes to dietary supple-mentation with resistant starch. Microbiome 4:33. https://doi.org/10.1186/s40168-016-0178-x.
11. Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. 2002. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 45:621–627. https://doi.org/10.1007/s10350-004-6257-2.
12. Le Leu RK, Hu Y, Brown IL, Young GP. 2009. Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats. Nutr Metab (Lond) 6:11. https://doi.org/10.1186/1743-7075-6-11.
13. Harsch IA, Konturek PC. 2018. The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into “old” diseases. Med Sci (Basel) 6:E32. https://doi.org/10.3390/medsci6020032.
14. Brown JM, Hazen SL. 2018. Microbial modulation of cardiovascular disease. Nat Rev Microbiol 16:171–181. https://doi.org/10.1038/nrmicro.2017.149.
15. Makki K, Deehan EC, Walter J, Backhed F. 2018. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23:705–715. https://doi.org/10.1016/j.chom.2018.05.012.
16. Deehan EC, Duar RM, Armet AM, Perez-Munoz ME, Jin M, Walter J. 2017. Modulation of the gastrointestinal microbiome with nondigestible ferment-able carbohydrates to improve human health. Microbiol Spectr 5(5):BAD-0019-2017. https://doi.org/10.1128/microbiolspec.BAD-0019-2017.
17. Cockburn DW, Koropatkin NM. 2016. Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. J Mol Biol 428:3230–3252. https://doi.org/10.1016/j.jmb.2016.06.021.
18. Watson D, O’Connell Motherway M, Schoterman MH, van Neerven RJ, Nauta A, van Sinderen D. 2013. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol 114:1132–1146. https://doi.org/10.1111/jam.12105.
19. Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. 2012. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3:289–306. https://doi.org/10.4161/gmic.19897.
20. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ. 2006. Two routes of metabolic cross-feeding between Bifidobacte-rium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72:3593–3599. https://doi.org/10.1128/AEM.72.5.3593-3599.2006.
21. Louis P, Flint HJ. 2017. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 19:29–41. https://doi.org/10.1111/1462-2920.13589.
22. Ze X, Duncan SH, Louis P, Flint HJ. 2012. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 6:1535–1543. https://doi.org/10.1038/ismej.2012.4.
23. Bednar GE, Patil AR, Murray SM, Grieshop CM, Merchen NR, Fahey GC, Jr. 2001. Starch and fiber fractions in selected food and feed ingredients affect their small intestinal digestibility and fermentability and their large bowel fermentability in vitro in a canine model. J Nutr 131: 276–286. https://doi.org/10.1093/jn/131.2.276.
24. Leitch EC, Walker AW, Duncan SH, Holtrop G, Flint HJ. 2007. Selective colonization of insoluble substrates by human faecal bacteria. Environ Microbiol 9:667–679. https://doi.org/10.1111/j.1462-2920.2006.01186.x.
25. El Kaoutari A, Armougom F, Gordon JI, Raoult D, Henrissat B. 2013. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol 11:497–504. https://doi.org/10.1038/nrmicro3050.
26. Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S, Matteuzzi D. 2005. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 71:6150–6158. https://doi.org/10.1128/AEM.71.10.6150-6158.2005.
27. Moens F, De Vuyst L. 2017. Inulin-type fructan degradation capacity of Clostridium cluster IV and XIVa butyrate-producing colon bacteria and their associated metabolic outcomes. Benef Microbes 8:473–490. https://doi.org/10.3920/BM2016.0142.
28. Falony G, Vlachou A, Verbrugghe K, De Vuyst L. 2006. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72:7835–7841. https://doi.org/10.1128/AEM.01296-06.
29. Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG. 2015. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 362:fnv176. https://doi.org/10.1093/femsle/fnv176.
30. Scardovi V, Trovatelli LD. 1965. The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium. Ann Microbiol 15:19–29.
31. Allen-Vercoe E, Daigneault M, White A, Panaccione R, Duncan SH, Flint HJ, O’Neal L, Lawson PA. 2012. Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. Anaerobe 18:523–529. https://doi.org/10.1016/j.anaerobe.2012.09.002.
32. Duncan SH, Louis P, Flint HJ. 2004. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70:5810–5817. https://doi.org/10.1128/AEM.70.10.5810-5817.2004.
33. Kelly WJ, Asmundson RV, Hopcroft DH. 1987. Isolation and characterization of a strictly anaerobic, cellulolytic spore former: Clostridium char-tatabidum sp. nov. Arch Microbiol 147:169–173. https://doi.org/10.1007/BF00415279.
34. Yang JC, Chynoweth DP, Williams DS, Li A. 1990. Clostridium aldrichii sp. nov, a cellulolytic mesophile inhabiting a wood-fermenting anaerobic digester. Int J Syst Bacteriol 40:268–272. https://doi.org/10.1099/00207713-40-3-268.
35. Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer K-H, Whitman W (ed). 2009. Bergey’s manual of systematic bacteriology, vol3. The Firmicutes. Springer-Verlag, New York, NY.
36. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ. 2011. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5:220–230. https://doi.org/10.1038/ismej.2010.118.
37. Martinez I, Kim J, Duffy PR, Schlegel VL, Walter J. 2010. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 5:e15046. https://doi.org/10.1371/journal.pone.0015046.
38. Nielsen TH, Wischmann B, Enevoldsen K, Moller BL. 1994. Starch phos-phorylation in potato tubers proceeds concurrently with de novo bio-bio-synthesis of starch. Plant Physiol 105:111–117. https://doi.org/10.1104/pp.105.1.111. synthesis
39. Donaldson GP, Lee SM, Mazmanian SK. 2016. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14:20–32. https://doi.org/10.1038/nrmicro3552.
40. Cockburn DW, Suh C, Medina KP, Duvall RM, Wawrzak Z, Henrissat B, Koropatkin NM. 2018. Novel carbohydrate binding modules in the surface anchored alpha-amylase of Eubacterium rectale provide a molecular rationale for the range of starches used by this organism in the human gut. Mol Microbiol 107:249–264. https://doi.org/10.1111/mmi.13881.
41. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalová L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E. 2015. Personalized nutrition by prediction of glycemic responses. Cell 163: 1079–1094. https://doi.org/10.1016/j.cell.2015.11.001.
42. Niness KR. 1999. Inulin and oligofructose: what are they? J Nutr 129: 1402S–1406S. https://doi.org/10.1093/jn/129.7.1402S.
43. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 79:5112–5120. https://doi.org/10.1128/AEM.01043-13.
44. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537–7541. https://doi.org/10.1128/AEM.01541-09.
45. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x.